pyridoxal phosphate has been researched along with angiotensin ii in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| el-Sherbeeny, M; Khayyal, MA; Khayyal, MT; Okpanyi, SN; Schneider, W; Sharaf, HM | 1 |
| Jankowski, J; Luo, J; Schlüter, H; Schröter, A; Stephan, N; Tepel, M; van der Giet, M; Zidek, W | 1 |
| Bivalacqua, TJ; Champion, HC; De Witt, BJ; Inscho, EW; Kadowitz, PJ; Shah, MK | 1 |
| Graciano, ML; Jackson, K; Kobori, H; Navar, LG; Nishiyama, A; Ortiz, RM; Prieto-Carrasquero, MC; Seth, DM | 1 |
4 other study(ies) available for pyridoxal phosphate and angiotensin ii
| Article | Year |
|---|---|
Effect of magnesium pyridoxal 5-phosphate glutamate on vascular reactivity in experimental hypercholesterolemia.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Pressure; Cholesterol, Dietary; Clonidine; Drug Evaluation, Preclinical; Glutamine; Histamine; Hypercholesterolemia; Hypolipidemic Agents; In Vitro Techniques; Male; Norepinephrine; Pyridoxal Phosphate; Rabbits; Vasoconstrictor Agents; Vasomotor System | 1998 |
Isolation and characterization of coenzyme A glutathione disulfide as a parathyroid-derived vasoconstrictive factor.
Topics: Acetates; Angiotensin II; Animals; Cell Division; Cells, Cultured; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Coenzyme A; Disulfides; Dose-Response Relationship, Drug; Glutathione; Humans; Mercaptoethanol; Molecular Weight; Muscle, Smooth, Vascular; Parathyroid Glands; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Theobromine; Vasoconstrictor Agents | 2000 |
Comparative responses to alpha,beta-methylene-ATP in cat pulmonary, mesenteric, and hindquarter vascular beds.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Angiotensin II; Animals; Blood Vessels; Cats; Dose-Response Relationship, Drug; Female; Hindlimb; Male; Mesenteric Arteries; Perfusion; Pressure; Prostaglandin-Endoperoxide Synthases; Pulmonary Circulation; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Vasoconstrictor Agents | 2002 |
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.
Topics: Actins; Adenosine Triphosphate; Angiotensin II; Animals; Arterioles; Blood Pressure; Cell Proliferation; Clopidogrel; Disease Models, Animal; Hypertension; Hypertrophy; Kidney; Male; Membrane Proteins; Mesangial Cells; Purinergic Antagonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Renin; Ticlopidine | 2008 |